Cargando…
PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells
Chemotherapy is one of the main therapeutic modalities for cancer patients. Cisplatin (CDDP), as one of the first-line drugs, is of great importance in the chemotherapy of various tumors. However, a significant percentage of cancer patients are resistant to CDDP treatment. Due to the CDDP side effec...
Autores principales: | NAVAEI, ZAHRA NASRPOUR, KHALILI-TANHA, GHAZALEH, ZANGOUEI, AMIR SADRA, ABBASZADEGAN, MOHAMMAD REZA, MOGHBELI, MEYSAM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tech Science Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208004/ https://www.ncbi.nlm.nih.gov/pubmed/37303943 http://dx.doi.org/10.32604/or.2022.025323 |
Ejemplares similares
-
MicroRNA-506 as a tumor suppressor in anaplastic thyroid carcinoma by regulation of WNT and NOTCH signaling pathways
por: Nasrpour Navaei, Zahra, et al.
Publicado: (2023) -
Long non-coding RNAs as the critical regulators of epithelial mesenchymal transition in colorectal tumor cells: an overview
por: Hamidi, Amir Abbas, et al.
Publicado: (2022) -
MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells
por: Zangouei, Amir Sadra, et al.
Publicado: (2021) -
Molecular mechanisms of the microRNA-132 during tumor progressions
por: Moghbeli, Meysam, et al.
Publicado: (2021) -
MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells
por: Maharati, Amirhosein, et al.
Publicado: (2022)